1. Australas J Dermatol. 2022 Aug;63(3):e279-e282. doi: 10.1111/ajd.13866. Epub 
2022 May 5.

A review of the cutaneous toxicities of tebentafusp-Featuring two cases 
involving superficial bullous reactions.

Pham JP(1)(2), Star P(1), Ardolino L(1)(2)(3), Smith A(1)(4)(5), Joshua 
AM(1)(2)(3)(5).

Author information:
(1)St. Vincent's Hospital Sydney, Darlinghurst, New South Wales, Australia.
(2)St Vincent's Clinical School, University of New South Wales, Sydney, New 
South Wales, Australia.
(3)Department of Medical Oncology, The Kinghorn Cancer Centre, Darlinghurst, New 
South Wales, Australia.
(4)Faculty of Medicine and Health, University of Sydney, Sydney, New South 
Wales, Australia.
(5)Melanoma Institute of Australia, New South Wales, Australia.

DOI: 10.1111/ajd.13866
PMID: 35510367 [Indexed for MEDLINE]
